No More Silence: US FDA Clears First-Ever Gene Therapy For Children Born Deaf Due To Genetic Mutation Post author:mck Post published:April 25, 2026 Post category:Blog American drugmaker Regeneron’s Otarmeni can restore natural hearing in children born deaf due to a genetic mutation You Might Also Like India denounces ‘hellhole’ remark shared by Trump April 24, 2026 Zelenskyy says Russian drone strikes Chernobyl February 14, 2025 US Commerce Secretary Lutnick to testify before Congress about Epstein ties March 4, 2026